Patent · US Active

Controlling light exposure for circadian phase management

US11707595B2 · kind B2 · utility

0Cited by
8References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 24, 2019
Grant dateJul 25, 2023
Priority date
Expiry dateMar 10, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N2005/0663
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

This disclosure pertains to a system configured to control light exposure for circadian phase management and/or light deficient disorders of a subject. The system comprises a user interface, physiological sensors configured to generate output signals conveying physiological data of the subject, and a light control valve configured to block or reduce blue light ambient radiation reaching eyes of the subject. Processors are in communication with the user interface, the physiological sensors, the light control valve, and radiation generators. The processors cause the system to receive physiological goals of the subject, determine a light control plan based on the physiological goals, the physiological data, environmental data, and time data. The system operates the light control valve to block or reduce blue light ambient radiation based on the light control plan, and generate, using the one or more radiation generators, therapeutic light radiation based on the light control plan.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.